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Background: The features of early-phase acute respiratory distress syndrome (ARDS) are leakage of fluid into the
extravascular space and impairment of its reabsorption, resulting in extravascular lung water (EVLW) accumulation.
The current study aimed to identify how the initial EVLW values and their change were associated with mortality.
Methods: This was a post hoc analysis of the PiCCO Pulmonary Edema Study, a multicenter prospective cohort
study that included 23 institutions. Single-indicator transpulmonary thermodilution-derived EVLW index (EVLWi) and
conventional prognostic factors were prospectively collected over 48 h after enrollment. Associations between
28-day mortality and each variable including initial (on day 0), mean, maximum, and Δ (subtracting day 2 from
day 0) EVLWi were evaluated.
Results: We evaluated 192 ARDS patients (median age, 69 years (quartile, 24 years); Sequential Organ Failure
Assessment (SOFA) score on admission, 10 (5); all-cause 28-day mortality, 31%). Although no significant differences
were found in initial, mean, or maximum EVLWi, Δ-EVLWi was significantly higher (i.e., more reduction in EVLWi) in
survivors than in non-survivors (3.0 vs. −0.3 mL/kg, p = 0.006). Age, maximum, and Δ-SOFA scores and Δ-EVLW were
the independent predictors for survival according to the Cox proportional hazard model. Patients with Δ-EVLWi >
2.8 had a significantly higher incidence of survival than those with Δ-EVLWi≤ 2.8 (log-rank test, χ2 = 7.08, p = 0.008).
Conclusions: Decrease in EVLWi during the first 48 h of ARDS may be associated with 28-day survival. Serial EVLWi
measurements may be useful for understanding the pathophysiologic conditions in ARDS patients. A large
multination confirmative trial is required.
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Acute respiratory distress syndrome (ARDS) is character-
ized by life-threatening hypoxemia with high mortality
rates [1-3]. In the early phase of ARDS (i.e., pathologically
‘exudative stage’), intravascular fluid leakage into the inter-
stitium and alveoli of the lung due to diffuse alveolar dam-
age results in accumulation of extravascular lung water
(EVLW) [4,5]. Recently, the transpulmonary thermodilu-
tion technique has facilitated bedside quantitative evalu-
ation of EVLW, as well as its indexed value extravascular
lung water index (EVLWi, mL/kg), with robust validation
in both accuracy and precision [6-9]. Consistent with the
pathological concept, recent studies indicated that the
EVLWi value represented the severity of lung injury in
ARDS patients [10-13]. Moreover, previous studies sug-
gested that increasing absolute EVLWi values in the early
phase of ARDS (i.e., increase in initial EVLWi [14,15],
mean EVLWi for the first 3 days [16], and EVLWi on day
2 [12]) were associated with patient mortality.
Reabsorption of EVLW can also be impaired during the
early phase of ARDS in addition to the primary leakage of
fluid to the extravascular space [4,17]. The landmark study
by Ware and Matthay [18] showed that impaired alveolar
fluid clearance early in the course of ARDS was well corre-
lated with poor clinical outcome. Consistent with these
pathophysiological disturbances (i.e., impaired reabsorp-
tion of EVLW), changes in EVLWi (Δ-EVLWi) in the early
phase of acute respiratory failure may constitute a signifi-
cant predictor of survival [19,20].
Cordemans et al. [20] previously reported that the max-
imum difference between EVLWi measurements during
the patient's stay in the intensive care unit (ICU) was re-
lated to poor prognosis. More recently, Jozwiak et al. [21]
reported that the maximum value of EVLWi over the
entire ARDS episode was an independent risk factor for
mortality. Thus, continuous leakage due to persistent pre-
cipitating underlying causes and/or impairment of EVLW
reabsorption may result in a poor outcome [20-22]. How-
ever, the maximum EVLWi value reached during an ICU
stay or ARDS episode cannot be predicted on a given day
in clinical practice; thus, evaluating changes in early
EVLWi might be more useful for accurate evaluation of
the pathophysiological condition [21].
Therefore, the aim of the current study was to identify
how the initial EVLW values and their changes were as-
sociated with mortality in adult ARDS patients by re-
analyzing a large multicenter cohort study database.
Methods
Design and patients
The current study was a post hoc analysis of the PiCCO
Pulmonary Edema Study, a multicenter prospective cohort
study that examined respiratory-distressed patients admit-
ted to 23 participating institutions in Japan [10,23-26].This study was approved by the ethics committees of all
23 institutions, and written informed consent was ob-
tained from all patients or their next of kin.
The primary inclusion criteria were age of >15 years (no
upper age limit), mechanical ventilation (expected dur-
ation, >48 h) required for acute respiratory failure with a
PaO2/FiO2 ratio of ≤300 mmHg, and bilateral infiltration
on chest radiography. An EVLWi of >10 mL/kg was used
to define pulmonary edema, in accordance with defini-
tions in previous reports [8,10,13,27]. Exclusion criteria
were as follows: >5 days from the onset of acute respi-
ratory failure; chronic respiratory insufficiency; history of
pulmonary resection, pulmonary thromboembolism, or
severe peripheral arterial disease; cardiac index of <1.5 L/
min/m2; lung contusion; or burns as well as other causes
rendering the patient unsuitable for evaluation with the
transpulmonary thermodilution technique [23].
The pathophysiological differential diagnosis for respira-
tory insufficiency was performed by at least three experts
(specializing in intensive care, respirology, and cardiology),
who retrospectively determined the pathophysiological me-
chanism of respiratory insufficiency as (a) cardiogenic
(hydrostatic) pulmonary edema, (b) permeability pulmon-
ary edema (i.e., ARDS), or (c) pleural effusion with atelec-
tasis but no evidence of lung edema secondary to increased
hydrostatic pressure or vascular permeability as previously
described [23]. For this purpose, the experts carefully scru-
tinized the patient's medical history, clinical presentation
and course, and findings of chest computed tomography,
radiography, and echocardiography. They also considered
the time course of all the preceding findings, including
daily fluid intake and output, and the balance thereof, and
requirement of systemic management and respiratory ther-
apy. The hospital type was categorized as academic or non-
academic. Hospital volume was defined as the number of
patients that participated in the current analysis and was
categorized into tertiles (i.e., low, medium, and high).
We considered the increased permeability pulmonary
edema group (i.e., (b) above) as ARDS [10,23] and in-
cluded the corresponding patients in the current study. At
the time of enrollment (day 0), the patient was evaluated
with regard to clinical condition, cause of respiratory in-
sufficiency, Sequential Organ Failure Assessment (SOFA)
score [28], and echocardiography chest computed tomog-
raphy. Blood samples were obtained via the arterial cath-
eter at the same time as thermodilution measurements
were performed.
Thermodilution measurements
A 4- or 5-French arterial thermistor-tipped catheter
(PV2014L16N, PV2014L22N, or PV2015L20N; Pulsion
Medical Systems, Munich, Germany) was inserted in all
patients and connected to a PiCCO® monitoring system
(PiCCO Plus system or PiCCO 2 system) or Philips
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Eindhoven, The Netherlands) equipped with a PiCCO
technology module. Previous reports have discussed the
principles and validation of these single-indicator trans-
pulmonary thermodilution-derived variables [20,29,30].
In short, a 15-mL bolus of cold normal saline was
injected through a central venous catheter. The thermo-
dilution curves were then recorded from the thermistor
of the PiCCO catheter to allow for estimation of cardiac
output, global end-diastolic volume (GEDV) [31], EVLW,
pulmonary vascular permeability index (PVPI) [23], global
ejection fraction, and systemic vascular resistance index.
The principles and validation of these single-indicator
transpulmonary thermodilution-derived variables have been
discussed in detail previously [32,33]. We collected the data
of absolute EVLW value. The absolute EVLW value was
indexed to predicted body weight, calculated as 50 + 0.91
(height (cm) − 152.4) for males and 45.5 + 0.91 (height
(cm) − 152.5) for females [23,34]. For indexing EVLW,
the predicted body weight (EVLWi; normal range, 7.4 ±
3.3 mL/kg) instead of the actual body weight was used be-
cause the EVLWi has been shown to be a better prognos-
tic indicator than EVLW indexed to the actual body
weight [8,11,14,16,35]. Measurements were performed
every 24 h for 3 days. The intervention and treatment were
decided by the attendant doctors at each institution, most
of which follow the Japanese ARDS guidelines ‘Guideline
for ALI/ARDS diagnosis and treatment’ (second edition)
[36]. The PiCCO® system was only used for passive
monitoring, and no treatment algorithm based on pa-
rameters obtained with transcardiopulmonary thermo-
dilution was used.
Outcomes
The principal outcome measures were survival within
28 days and the initial, mean, maximum, and Δ-EVLWi
(subtracting EVLWi day 2 from day 0).
Statistical analysis
Data were expressed as mean (±SD) or median (quartile),
as appropriate. Patients were divided into two groups ac-
cording to survival at day 28. Continuous variables were
compared between the groups using the t test or Mann-
Whitney U test for continuous variables, as appropriate.
Categorical variables were analyzed using the chi-square
test or Fisher's exact test. Areas under the receiver oper-
ator characteristic (ROC) curves (AUC) for SOFA and
EVLWi variables (i.e., initial, mean, maximum, and Δ) to
predict 28-day survival were calculated. The Youden index
was used to determine the cutoff value for the variables
regarding 28-day survival. Cox proportional hazard ana-
lysis (forward stepwise methods) was used to estimate haz-
ard ratio after accounting for a priori factors (age, sex, and
cumulative fluid balance) and other variables of p < 0.15based on univariate analyses as the selection criterion. Pa-
tients were then divided into two groups according to the
cutoff value estimated by the Youden index, and survival
analysis was performed using Kaplan-Meier plots with
log-rank statistics between the groups. All data were ana-
lyzed using SPSS 22.0 for Windows (IBM, Armonk, NY,
USA) and Stat Flex 6.0 for Windows (Artech, Osaka,
Japan); p < 0.05 was considered significant.
Results
Patients
From March 2009 to August 2011, 301 patients with re-
spiratory insufficiency were enrolled in the PiCCO Pul-
monary Edema Study [23]. Of the 301 patients initially
recruited, 192 matched the inclusion criteria for this ana-
lysis (Figure 1). Overall, the median age of the patients was
69 (24) and the initial SOFA score was 10 (5). Fifty-nine
(30.7%) patients died within 28 days after admission. The
192 patients were separated into survivors and non-
survivors at day 28 (Table 1). The survivors had signifi-
cantly lower SOFA scores, lower creatinine levels, and
lower cumulative fluid balance values (Table 1).
Thermodilution measurement variables
Although there was no significant difference between
the survivors and non-survivors with respect to initial,
mean, maximum, or Δ-GEDV nor initial, mean, or
maximum-EVLWi, significant differences existed for
Δ-EVLWi (Table 2). Comparison of serial EVLWi in survi-
vors and non-survivors is presented in Figure 2. Further-
more, 71% of the survivors exhibited an improvement
(increase) in Δ-EVLWi, compared with 54% of the non-
survivors (p = 0.02).
ROC analysis
AUC of ROC analyses to predict 28-day survival for each
SOFA variable, i.e., initial, mean, maximum, and Δ-SOFA,
were 0.65 (95% CI, 0.57 to 0.73, p = 0.001), 0.71 (0.64 to
0.79, p < 0.001), 0.70 (0.63 to 0.78, p < 0.001), and 0.66
(0.58 to 0.74, p < 0.001), respectively. There was no signifi-
cant AUC difference among the SOFA variables.
AUC of ROC analyses to predict 28-day survival for
each EVLWi variable, i.e., initial, mean, maximum, and
Δ-EVLWi, were 0.50 (0.41 to 0.59, p = 0.98), 0.55 (0.46
to 0.64, p = 0.29), 0.52 (0.42 to 0.61, p = 0.72), and 0.62
(0.53 to 0.70, p = 0.01), respectively. Although the value
of AUC for Δ-EVLWi was higher than that for initial-
EVLW, it did not reach a statistically significant level
(0.62 vs. 0.50, p = 0.06).
The Δ-EVLWi threshold that was best associated with
28-day mortality was 2.8 as estimated by the Youden index
(70% sensitivity, 51% specificity, 39% positive predictive
value, 79% negative predictive value). Patients with Δ-
EVLWi > 2.8 had a significantly higher incidence of survival
Figure 1 Flow diagram of patient enrollment. Missing important data: extravascular lung water index data missing either on day 0, day 1, or day 2.
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78.8% vs. 61.7%, p = 0.01). The Kaplan-Meier survival curve
showed a significant time-dependent difference between
patients with Δ-EVLWi > 2.8 and Δ-EVLWi ≤ 2.8 during
28 days (log-rank test, χ2 = 7.08, p = 0.008) (Figure 3).
Cox proportional hazard model analysis
Factors as a priori and in accordance with the results of
the univariate analyses as presented in Tables 1 and 2,
age; sex; cumulative fluid balance; initial-, mean-, max-
imum-, and Δ-SOFA scores; serum creatinine level; use
of renal replacement therapy; mean- and Δ-EVLWi; and
Δ-PVPI were entered (p < 0.15 on univariate analysis) in
the Cox proportional hazard model for 28-day survival.
Age; maximum- and Δ-SOFA scores; and Δ-EVLWi
were independently associated with survival (Table 3).
Discussion
The current study suggested that change in EVLWi dur-
ing the first 48 h - and not initial, mean, or maximumEVLWi value - was associated with 28-day survival. In
addition, Δ-EVLWi was one of the independent factors
that was associated with the time-dependent influence
on survival even after adjustment for age and maximum
and Δ-SOFA scores. Δ-EVLWi may represent the patho-
physiologic status of ARDS recovery.
The strength of the current study was that we re-
evaluated prospectively collected data from 23 institutions
with relatively large sample data. Although the EVLW ap-
pears a promising variable for prediction of prognosis in
ARDS patients and representation of the pathophysiologic
state of ARDS, relevant previous studies were all single-
center (or two-center) studies [12,14-16,19-21], and most
included only a limited number of patients [12,14-16,19].
On the other hand, the current results suggest that Δ-
EVLWi alone might not be adequate as a practical and
useful parameter to predict mortality. Although higher
than the AUC for mortality of the American-European
Consensus Conference (AECC) definition or recently re-
vised Berlin definition (0.536; 95% CI, 0.520 to 0.553 and
Table 1 Patient characteristics according to survival at day 28
Patient characteristics Survivors (n = 133) Non-survivors (n = 59) p value
Sex (male), n (%) 88 (66.2) 37 (62.7) 0.64
Age, years 68 (23) 72 (19) 0.05
Hospital type (academic), n (%) 87 (65.4) 33 (55.9) 0.26
Hospital volume, n (%) 0.95
≤8 44 (33.1) 20 (33.9)
9 to 14 46 (34.6) 19 (32.2)
≥14 43 (32.3) 20 (33.9)
Direct lung injury, n (%) 78 (58.6) 39 (66.1) 0.39
SOFA score on day 0 10 (5) 11 (5) <0.001
Mean SOFA score for 3 days, mean ± SD 9.6 ± 4.5 11.3 ± 4.3 <0.001
Maximum SOFA score 11 (5) 13 (5) <0.001
Δ-SOFA score, mean ± SD 0.89 ± 2.1 0.53 ± 2.3 <0.001
Mean arterial pressure, mmHg 76 (24) 77 (22) 0.61
Central venous pressure, mmHg 10 (6) 10 (9) 0.89
PaO2/FiO2, mmHg 151.4 (112) 138.1 (103) 0.14
Serum albumin, mg/dL 2.5 (0.9) 2.6 (0.8) 0.84
Serum creatinine, mg/dL 0.9 (1.1) 1.4 (1.4) 0.003
Diuretic use, n (%) 68 (51.1) 28 (47.4) 0.64
Renal replacement therapy, n (%) 32 (24.1) 21 (35.6) 0.10
Steroid use, n (%) 49 (36.8) 24 (40.7) 0.61
Use of vasopressors, n (%) 91 (68.4) 44 (74.6) 0.39
Cumulative fluid balance over 48 h, mL 3,015 (4,918) 4,595 (6,187) 0.02
Data were shown in median (quartile) unless otherwise presented. Hospital volume was defined as the number of patients that participated in the current analysis
and was categorized into tertiles (i.e., low, medium, and high). SOFA, Sequential Organ Failure Assessment.
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dictive value of AUC for mortality for Δ-EVLWi was only
0.62 in the present study. In addition, corresponding sensi-
tivity, specificity, and positive/negative predictive values
for Δ-EVLWi threshold that was best associated with 28-
day mortality were relatively low. Moreover, effect size of
Δ-EVLWi was small with a hazard ratio of 0.95 according
to the Cox analysis. However, the main interest of the
current study was the validation of the transpulmonary
thermodilution-derived EVLWi, which not only predicts
mortality but also may represent pathophysiological con-
dition in the early phase of ARDS.
Mortality rates in ARDS are greatly influenced by the
age of the patient and presence of non-pulmonary organ
dysfunctions, and patients die more commonly from
multiple organ failure than respiratory failure [2,38].
Therefore, a scoring system that represents organ dys-
functions - the SOFA score - and its changes over time
must be good predictors of survival in ARDS. The re-
sults of the current study revealed that maximum and
Δ-SOFA scores were associated with the prognosis in
clinical situations, which was consistent with the previ-
ous study [28]. Importantly, the current results showedthat Δ-EVLWi was also an independent predictor of sur-
vival even after adjustment for age and maximum and
Δ-SOFA scores. Thus, our results suggest that ARDS
patients with potential multiple organ failure had co-
morbid conditions that hindered EVLW improvement.
This phenomenon is consistent with the results of pre-
vious studies that revealed that compromised reabsorp-
tion of fluid in extravascular space is common in ARDS
patients and is correlated with poor clinical outcome
[4,17,18]. Conversely, Δ-EVLWi may represent the patho-
physiologic status of recovery in ARDS [12,20-22]. Our re-
sults were similar to the findings obtained by Cordemans
et al. [20], who reported that the maximum difference
between EVLWi measurements during the ICU stay was
related to poor prognosis. Because maximum EVLWi can-
not be identified in a given day, we defined Δ-EVLWi as
the difference between the values at day 2 and day 0 (48 h)
in the current study. We therefore believe that serial mea-
surements of the EVLWi value and simple calculation of
Δ-EVLWi in the first 48 h may aid understanding of the
pathophysiological condition in ARDS.
Our data are inconsistent with previous ARDS studies
that reported the prognostic value of initial, mean, or
Figure 2 Comparison of serial EVLWi in survivors (square) and
non-survivors (diamond). Error bar indicates 95% confidence
interval. *p = 0.006.
Table 2 Transpulmonary thermodilution data during the study period according to survival at day 28
Patient characteristics Survivors (n = 133) Non-survivors (n = 59) p value
GEDVi on day 0, mL/m2 825 ± 212 808 ± 199 0.58
Mean GEDVi for 3 days, mL/m2 835 ± 197 832 ± 191 0.92
Maximum GEDVi, mL/m2 937 ± 251 932 ± 216 0.90
Day of maximum GEDVi measurement, n (%) 0.45
Day 0 40 (30.1) 18 (30.5)
Day 1 45 (33.8) 15 (25.4)
Day 2 48 (36.1) 26 (44.1)
Δ-GEDVi, mL/m2 −29 ± 198 −63 ± 199 0.26
EVLWi on Day 0, mL/kg 18.4 ± 6.7 18.3 ± 6.5 0.90
Mean EVLW for 3 days, mL/kg 17.0 ± 5.4 18.5 ± 7.2 0.11
Maximum EVLW, mL/kg 20.7 ± 7.3 21.8 ± 9.2 0.36
Day of maximum EVLWi measurement, n (%) 0.14
Day 0 64 (48.1) 21 (35.6)
Day 1 49 (36.8) 23 (39.0)
Day 2 20 (15.0) 15 (25.4)
Δ-EVLWi, mL/kg 3.0 ± 7.4 −0.3 ± 7.6 0.006
PVPI on Day 0 3.2 ± 1.3 3.2 ± 1.4 0.98
Mean PVPI for 3 days 2.9 ± 1.0 3.1 ± 1.3 0.21
Maximum PVPI 3.6 ± 1.4 3.8 ± 1.8 0.40
Day of maximum PVPI measurement, n (%) 0.17
Day 0 76 (57.1) 25 (42.4)
Day 1 36 (27.1) 22 (37.3)
Day 2 21 (15.8) 12 (20.3)
Δ-PVPI 0.6 ± 1.3 0.2 ± 1.4 0.06
EVLWi, extravascular lung water index; GEDVi, global end-diastolic volume index; PVPI, pulmonary vascular permeability index; Δ-EVLWi, reduction in EVLWi from
day 2 to day 0; Δ-GEDVi, reduction in GEDVi from day 2 to day 0; Δ-PVPI, reduction in PVPI from day 2 to day 0.
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planation for the selection of initial and mean EVLWi as
significant variables associated with prognosis may be an
effect of the inclusion criteria used in those previous
studies [12,14,16,21], where ARDS was diagnosed on the
basis of the AECC criteria [37]. Although the AECC cri-
teria are simple and widely used, significant criticisms
have been reported in terms of their diagnostic validity
[1,13,27,39,40]. Martin et al. [41] suggested that 1/3 of
the patients fulfilling the AECC criteria did not have ele-
vated EVLWi, and these patients had improved survival
compared with patients with increased EVLWi. As a re-
sult, patients with a wide variety of EVLWi values were
entered in the previous ARDS studies, which might have
contributed to detection of the initial or mean EVLWi
value as a good prognostic factor even in a small sample
size [12,14,16]; approximately 1/4 of the studied patients
were reported as having an EVLWi of <7 mL/kg [12] or
<10 mL/kg [14], which were considered within normal
range [8,13,27,42]. Therefore, these patients may not
have had ARDS pathologically because a recent study
Figure 3 Kaplan-Meier survival curves for patients that were categorized by Δ-EVLWi > 2.8 or Δ-EVLWi ≤ 2.8. Significant differences were
found between the two groups (log-rank test: χ2 = 7.08, p = 0.008).
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quantitative discriminating threshold for the diagnosis of
diffuse alveolar damage [13]. Thus, patients with high
initial EVLWi (with diffuse alveolar damage) were as-
sumed to have poor outcome, which was consistent with
the findings reported among critically ill patients in gen-
eral (i.e., with heterogenous groups of patients) [33,43].
A recent large retrospective single-center study of 200
ARDS patients by Jozwiak et al. [21], only 2% of whom
had an EVLWi of <7 mL/kg, also suggested that there
was no difference in initial EVLWi value between non-
survivors and survivors (17 ± 9 mL/kg vs. 16 ± 7 mL/kg,
p = 0.25) [21]. In the current study, only ARDS patients
whose EVLWi was >10 mL/kg were included, which re-
sulted in a similar initial EVLWi value in non-survivors
and survivors (18.3 ± 6.5 mL/kg vs. 18.4 ± 6.7 mL/kg,
p = 0.90). Interestingly, although there was no difference
in the initial EVLWi between non-survivors and survivors,Table 3 Cox proportional hazards model analysis for the
prediction of 28-day survival
Hazard ratio (95% CI) p value
Age 1.02 (1.00 to 1.04) 0.02
Sex 0.99 (0.57 to 1.7) 0.97
Cumulative fluid balance 1.0 (0.99 to 1.0) 0.28
Δ-EVLWi 0.95 (0.92 to 0.98) 0.006
Maximum SOFA score 1.2 (1.1 to 1.4) <0.001
Δ-SOFA score 0.80 (0.71 to 0.91) <0.001
Δ-EVLWi, reduction in extravascular lung water index from day 2 to day 0;
SOFA, Sequential Organ Failure Assessment; Δ-SOFA, reduction in SOFA score
from day 2 to day 0.significant reductions in EVLWi were documented in sur-
vivors after 48 h in both studies, suggesting improvement
of Δ-EVLWi. In the current study, Δ-EVLWi was the only
significant and meaningful variable associated with 28-day
prognosis on ROC analysis, which was confirmed by the
subsequent Cox regression analysis and log-rank test.
Thus, more attention must be paid to Δ-EVLWi among
initially high EVLWi patients in present clinical practice
and in future studies.
Maximum EVLWi value was not a significant variable
associated with prognosis in the current study; this re-
sult differs from that of the study by Jozwiak et al. [21],
despite both studies having similar sample size and ini-
tial EVLWi value. The main reason for this discrepancy
may be the duration of the thermodilution evaluation
period. Although Jozwiak et al. [21] studied the whole
ARDS period (median duration of 12 days interquartile
range, [7-21]) to determine maximum EVLWi, we evalu-
ated data only for the first 3 days (48 h), which were con-
sidered to represent the early phase clinically and the
‘exudative stage’ pathologically. Thus, maximum EVLWi
might have appeared after the early phase of ARDS in the
current study. However, a physician performing a bedside
EVLWi measurement in an ARDS patient cannot predict
when the EVLW value will reach the maximum. On the
other hand, evaluation of Δ-EVLWi after the first 48 h of
intensive care is easily performed and a practical method
to incorporate into daily clinical practice.
There are several limitations regarding the current
study. First, 15 patients were excluded from the analysis
because EVLWi data were missing either on day 0, day
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spective multicenter study from 23 institutions. Inter-
vention and treatment were decided by the attendant
doctors at each institution, and no treatment algorithm
using parameters obtained with transcardiopulmonary
thermodilution was used. We could not evaluate center
effect on outcome because of the small sample size for
each of the institutions. In addition, we do not know
whether aggressive diagnostic and therapeutic inter-
ventions may change the outcome after recognition of
worsening Δ-EVLWi in the early phase of ARDS. The
presence of hemodynamic instability and need for fluid
resuscitation may have a significant impact on Δ-
EVLWi. We analyzed only 3-day EVLWi data; thus, ef-
fective fluid de-resuscitation might not yet have started.
Further interventional studies, including EVLWi-driven
management protocols, are required. Third, PVPI and
changes in PVPI were not different between survivors
and non-survivors incompatible with the results of
previous studies [10,21,44]. This inconsistency may be
explained by the small sample size of the selected pa-
tients and the imbalance between the survivors and
non-survivors (the number of survivors was more than
double the number of non-survivors). Although it did
not reach a statistically significant level, Δ-PVPI was
higher in survivors than non-survivors (0.6 vs. 0.2, p =
0.06). Because this was a retrospective post hoc analysis,
we did not perform sample size estimation in advance
for the current analysis. Fourth, even though mortality
in critically ill patients with ARDS is influenced by vari-
ous factors, we could not document the cause of death,
day of ICU stay on which the patient was enrolled in the
study, nor length of ICU stay because these data were
not available in the PiCCO Pulmonary Edema Study
database. Thus, all these limitations should be addressed
in the future by well-designed large-sample multination
prospective study.
Conclusions
Although the effect size was small in this study, Δ-EVLWi
during the first 48 h of ARDS in patients with high initial
EVLWi is easily calculated and may be related to 28-day
mortality. Serial extravascular lung water measurements
in the early phase of ARDS may be useful for the under-
standing of the pathophysiologic condition in ARDS pa-
tients. A large multination confirmative trial is required.
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